Track 13 - April 5 – 7, 2016
Meeting the Challenge in the Big Data-Centric World
Data security is defined by the processes and mechanisms in place that prevent data misuse and identify threat risks. However, many biological research data sources, from IP to genomic to mobile, require different levels of security. The reality is that it matters not where your data exists, but the ways in which data is accessed. Track 13 addresses security services for both cloud-based systems and traditional computing.
Tuesday, April 5
7:00 am Workshop Registration and Morning Coffee
8:00 – 11:30 Recommended Morning Pre-Conference Workshops*
Security Considerations for Virtual Research
12:30 – 4:00 pm Recommended Afternoon Pre-Conference Workshops*
Growth Strategy: Leveraging Cloud Scalability to Enable Rapid Growth and Change
* Separate registration required
2:00 – 6:00 Main Conference
5:00 – 7:00 Welcome Reception in the Exhibit Hall with Poster
Wednesday, April 6
7:00 am Registration Open and
9:00 Benjamin Franklin Awards and Laureate Presentation
9:30 Best Practices Awards Program
9:45 Coffee Break in the Exhibit Hall with Poster Viewing
10:50 Chairperson’s Opening Remarks
David LaBrosse, Strategic Partner Manager, NetApp Healthcare
11:00 Building the Bionic Cloud
Michaela Iorga, Ph.D., Senior Security Technical Lead for
Cloud Computing; Co-Chair, NIST Cloud Security Working Group; Co-Chair, NIST
Cloud Forensic Science Working Group, National Institute of Standards and
When coupling the continuously growing and changing landscape
of advance persistent threats with the explosion of “pervasive computing” or
“ambient intelligence” founded by the hyperconnectivity of “everyware”, we
reach a technical inflection point which calls for innovative solutions to support
the further development of a strong, secure backbone of the Internet of Things
(IoT) – a bionic cloud.
11:30 Adopting Public Cloud at Enterprise Scale: Public IaaS
Don Barber, Infrastructure Architect, Enterprise Computing, IT
Infrastructure & Operations, AstraZeneca
Public cloud adoption at scale requires significant
rethinking of enterprise systems, processes and culture. This talk outlines how
AstraZeneca IT has made this journey to offer public cloud as an enterprise
service by tackling challenges with provisioning, management, security and
qualification. Subject material will range broadly from technical issues to
policy challenges and workforce education needs, concluding with a few
predictions about the future.
12:00 pm Sponsored Presentation (Opportunity Available)
12:15 Bringing Data and Computing Together to Enable Research Innovation
Joe Corkery, M.D.,Senior Product Manager, Google Cloud Platform
We will discuss how the vast data storage, sharing, and computing capabilities of Google Cloud Platform have enabled numerous researchers to bring together previously unwieldy data sets to gain novel insights. We will also explore how access to Google's cloud resources enables researchers to revisit traditional approaches to data analysis and pursue new methodologies that would otherwise be out-of-reach in a traditional environment.
12:30 Session Break
12:40 Luncheon Presentation I: Making Cloud R&D Electronic Laboratory Environments a Reality
John Conway, Global Director, Strategy and Technology,
Research & Development, LabAnswer
The drivers behind moving
to Cloud-based, enterprise class, scientific software applications are
substantial, and the trend is rapidly gaining momentum. LabAnswer will showcase
examples and discuss the practical considerations of deploying electronic
laboratory environments (ELE) via the Cloud, including Electronic Laboratory
Notebooks, LIMS, etc. Capabilities and functionality topics to be addressed
include Data Governance, Entity Registration, Request/Sample/Inventory
Management, and Data Aggregation & Analytics.
1:10 Luncheon Presentation II: Large-Scale Cancer Genomics in the AWS Cloud
Brian O'Connor, Ph.D., Managing Director, Cloud Technologies, Informatics and Bio-Computing, The Ontario Institute for Cancer Research
Angel Pizarro, MSE, Technical Business Development Manager, Scientific Computing, Amazon Web Services
ICGC recently made available the genomes of approximately 1,300 cancer donors as part of the AWS Public Data Sets program. In this presentation, learn how the Ontario Institute of Cancer Research leverages the cloud to process large-scale data sets like ICGC and uniformly analyze 900 TB of data in less than four months.
1:40 Session Break
1:50 Chairperson’s Remarks
Tom Johnson, Senior Director & Product Manager, Pharma and
Life Sciences Services, Exostar
1:55 Cloud Computing in a GxP Environment
Krista Woodley, Director, Digital Quality and Risk Management,
We discuss the regulatory expectations and associated
challenges with moving to cloud-based solutions (SaaS, IaaS, PaaS). Discussion
points include requirements for vendor oversight, validation and maintenance of
2:25 Case Study: How Merck Is Leveraging Information Security
to Enable & Accelerate Clinical Trials
Andrew K. Porter, Director, Enterprise Architecture, IT
Planning & Innovation, Merck & Co.
Bringing data, applications and people together for clinical
trials takes too long, costs too much and leaves security gaps that threaten
intellectual property and regulatory compliance. Merck explains its cloud-based
solution to close these gaps and mitigate risks by leveraging entitlements
management and fine-grained provisioning to automate partner onboarding,
connect required applications and data, assign permissions and control access
by authenticating identities.
2:55 Why Would You NOT Use Public Clouds for Your Big Compute Workloads?
Jason Stowe, CEO, Cycle Computing
Up to now there’s been resistance to leveraging the cloud for
the compute and data intensive workloads that historically run on in-house HPC
environments. But genomics, computational chemistry, and other data collection
and analytics have outpaced internal capacity. The lure of zero queue times,
unlimited amounts of processing, and the ability to directly fit jobs to
budget/value instead to available capacity is proving impossible to resist.
This talk will highlight the risks and rewards of doing science in the cloud.
3:25 Refreshment Break in the Exhibit Hall with Poster Viewing
4:00 The Next Phase for Healthcare Privacy and Security -
Katherine Downing, Director, Practice Excellence, American
Health Information Management Association
Security and privacy are of huge importance in business as
our organizations continue to be the target of attack. Taking a holistic
approach using Information Governance is the next generation for privacy and
security. Information Governance is an organization-wide framework for managing
information throughout its lifecycle and for supporting the organization’s
strategy, operations, regulatory, legal, risk, and environmental requirements.
4:30 Securing Personal Genomic Data: The Potential of the
Richard Shute, Ph.D., Consultant, Curlew Research
More people are having their genomes sequenced and letting
sequencing companies use their data for research. What if people want to take
back control of their own data? How would they confidently and securely manage
their most highly personalized information? Blockchain technology (the global
ledger behind Bitcoin) could be the answer to securely protecting genomic
information and managing transactions associated with personal genomic data.
PRESENTATION: The Role of Cybersecurity Leadership in This New World
Mansur Hasib, D.Sc., CISSP, PMP, CPHIMS, Cybersecurity Professor and Author, University System of Maryland
The world has changed. Technology drives the mission of the bio-IT world today. Yet this world has been the subject of some of the most sensational data breaches and even ransomware. What are we doing wrong? Technology certainly does not appear to be the answer. Yet, organizations appear prepared to dump money on the problem. In a highly interactive session, Dr. Hasib shares his views and analysis on the importance of people, leadership, and culture in cybersecurity.
5:30 – 6:30 Best of Show Awards Reception in the Exhibit Hall
with Poster Viewing
Thursday, April 7
7:00 am Registration and Morning Coffee
10:00 Coffee Break in the Exhibit Hall and Poster Competition
10:30 Chairperson’s Opening Remarks
Dinesh Vandayar, Vice President, Personalized Medicine, SAP SE
10:40 Standardized Security Systems: How They Protect
Pharmaceutical Data from Breaches
Mollie Shields-Uehling, President, SAFE-BioPharma Association
Information security breaches are a problem. Globalization
and digitization of drug development relies on the Web to share information,
exposing patient data and scientific intellectual property to hacks. The
session reviews standardized security systems, and their use allowing the
secure free flow of information across firewalls among collaborating parties.
It includes best practices used by stakeholders such as Merck, GSK and Pfizer.
11:00 Possession is 9/10ths of the Law; Considerations and
Evaluations for IT Security Policies
Brian Bissett, Senior Member, Baltimore Section, Institute of
Electrical and Electronic Engineers (IEEE)
High-level IT security breaches have made the news numerous
times over the past year. Despite the awareness of the risks security breaches
pose to organizations, they are still occurring with alarming frequency across
all enterprises in both the public and private sector. Is this to become the
new norm or has it ushered in a catalyst for change?
11:20 Accessing and Utilizing Public Genomic Data: How Hard
Can It Be?
Dianne Pacheco, Information Security Officer, The Jackson
Gregg TeHennepe, IT Project Manager, The Jackson Laboratory
The world is awash in Big Data, including large public
genomic data sets such as TCGA. Access to these data sets is cited as a
high-priority need for research programs; however, the technical and
administrative logistics can be daunting. In this talk we will cover the
security policies and practices needed to satisfy the data use requirements
associated with major public genomic data sets.
11:40 Innovating, Reimaging, and Digitally Transforming Personalized Medicine
David Delaney, Ph.D., CMO, SAP SE
With a flexible platform and advanced analytics, new digital solutions from SAP are uniquely positioned to help advance personalized medicine. The SAP Foundation for Health and applications such as SAP Health Engagement support deeper insights and connect data silos. Bring together your mission-critical structured, unstructured, public private, and experimental health data to provide better patient outcomes.
12:10 pm Session Break
12:20 Luncheon Presentation (Sponsorship Opportunity
Available) or Lunch on Your Own
1:20 Dessert Refreshment Break in the Exhibit Hall with Poster
1:55 Chairperson’s Remarks
John M. Conley, J.D., Ph.D., William Rand Kenan, Jr. Professor
of Law, University of North Carolina, Chapel Hill; Counsel, Robinson Bradshaw
Taha A. Kass-Hout, M.D., MS, Chief Health Informatics Officer
& Director, Office of Health Informatics, FDA
precisionFDA is an informatics cloud-based platform for
ensuring the accuracy of Next-Generation Sequencing (NGS) tests by
crowdsourcing reference material and data. A key part of President Obama’s
Precision Medicine Initiative, it serves as a collaborative research effort
that will inform later regulatory pathways and decision making. During this
talk, Dr. Taha Kass-Hout, FDA’s Chief Health Informatics Officer, describes the
platform and its successes since the December 2015 beta release.
PRESENTATION: How the Plecosystem, Blockchain, and Federated Data Enclaves will Shape
Genomics Innovation and Application: Emerging Initiatives from the Global
Alliance for Genomics and Health
John E. Mattison, M.D., Chief Medical Information Officer,
Assistant Medical Director, Southern California Medical Group, Kaiser
Permanente; Co-Chair, eHealth Workgroup, Global Alliance for Genomics and
How can we maximize genomic research for the good of all citizens
without violating their privacy? We need powerful new approaches to ensure
ethical research without unwarranted risk to citizens who consent to use of
personal data. The Global Alliance for Genomics and Health includes worldwide
institutions seeking consensus on policy frameworks supported by creative
technical solutions to achieve these paired goals of higher value and lower
risk. I discuss progress to date.
PRESENTATION: Large-Scale Data Commons for Genomic and Clinical Data and the Changing
Landscape for Sharing Research Data
Robert Grossman, Ph.D., Director, Center for Data Intensive
Science (CDIS); Core Faculty, Institute for Genomics & Systems Biology and
Computation Institute, Professor of Medicine, Section of Genetic Medicine, University
Open commons containing large amounts of public biomedical
data from the research community can potentially dramatically speed up medical
research. We describe our experiences developing large-scale open source data
commons for genomic and associated clinical data. We also discuss options for
integrating and interoperating in-house genomic and clinical data with public
data commons and private data partnerships.
3:30 PANEL DISCUSSION: How
Will Data Sharing Innovations Fare in the Regulatory Environment?
Moderator: John M. Conley, J.D., Ph.D., William Rand Kenan,
Jr. Professor of Law, University of North Carolina, Chapel Hill; Counsel,
Robinson Bradshaw & Hinson
Robert Grossman, Ph.D., University of Chicago
Taha A. Kass-Hout, M.D., MS, FDA
John E. Mattison, M.D., Kaiser Permanente
Andrew K. Porter, Merck & Co.
Mollie Shields-Uehling, SAFE-BioPharma Association
The growth in patient healthcare and life sciences innovations can be attributed to technology enhancements like cloud computing, big data analytics and mobile applications, but may conflict with increasing regulatory compliance demands to ensure protection of healthcare life and quality as well as patient data privacy and security. This panel of esteemed technology solution providers and regulators debates real-world challenges and how regulation must also innovate at technology’s pace.
4:00 Conference Adjourns